Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection

Radiology

Volumn 232, Issue 3, 2004, Pages 815-822

  Even Sapir, Einat ^a   Parag, Yoav ^a   Lerman, Hedva ^a   Gutman, Mordechai ^b   Levine, Charles ^a   Rabau, Micha ^a   Figer, Arie ^a   Metser, Ur ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Computed tomography (CT), technology; Positron emission tomography (PET), technology; Radionuclide imaging, comparative studies; Rectum, neoplasms

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; IODINATED CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PELVIC NEOPLASMS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 4143116591     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2323031065     Document Type: Article

References (29)

1. Flamen P, Stroobants S, Van Cutsem E, et al. Additional value of whole body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-d-glucose in recurrent colorectal cancer. J Clin Oncol 1999; 17:894-901.
2. Huguier M, Houry S, Barrier A. Local recurrence of cancer of the rectum. Am J Surg 2001; 182:437-439.
3. Carrington B. Postoperative and postradiation pelvis. In: Hricak H, Carrington BM, eds. MRI of the pelvis: a text atlas. London, England: Dunitz, 1991; 519-555.
4. Lee JK, Stanley RJ, Sagel SS, Levitt RG, McClennan BL. CT appearance of the pelvis after abdomino-perineal resection for rectal carcinoma. Radiology 1981; 141:737-741.
5. Pijl ME, Chaoui AS, Wahl RL, van-Oostayen JA. Radiology of colorectal cancer. Eur J Cancer 2002; 38:887-898.
6. Lonneux M, Reffad AM, Detry R, Kartheuser A, Gigot JF, Pauwels S. FDG-PET improves the staging and selection of patients with recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 2002; 29: 915-921.
7. Kalff V, Hicks RJ, Ware RE, et al. The clinical impact of 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 2002; 43:492-499.
8. Keogan MT, Lowe VJ, Baker ME, McDermott VG, Lyerly HK, Coleman RE. Local recurrence of rectal cancer: evaluation with F18-fluorodeoxyglucose PET imaging. Abdom Imaging 1997; 22:332-337.
9. Ell PJ, von Schulthess GK. PET/CT: a new road map (editorial). Eur J Nucl Med Mol Imaging 2002; 29:719-720.
10. Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system-initial results. Radiology 2002; 225:575-581.
11. 18F-FDG PET/CT. J Nucl Med 2003; 44:170-176.
12. Nakamoto Y, Tatsumi M, Cohade C, Osman M, Marshall LT, Wahl RL. Accuracy of image fusion of normal upper abdominal organs visualized with PET/CT. Eur J Nucl Med Mol Imaging 2003; 30:597-602.
13. Lardinois D, Weder W, Hany T, et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348:2500-2507.
14. Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003; 44:1200-1209.
15. Cohade C, Osman M, Nakamoto Y, et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 2003; 44:412-416.
16. Coakley FV, Choi PH, Gougoutas CA, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 2002; 223:495-499.
17. Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med 2004; 45:266-271.
18. Even-Sapir E, Lerman H, Figer A, et al. Role of (18)F-FDG dual-head gamma-camera coincidence imaging in recurrent or metastatic colorectal carcinoma. J Nucl Med 2002; 43:603-609.
19. Yamada K, Ishizawa T, Niwa K, Chuman Y, Aikou T. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 2002; 45:1078-1084.
20. de Lange EE, Fechner RE, Wanebo HJ. Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings. Radiology 1989; 170:323-328.
21. Blomqvist L, Fransson P, Hindmarsh T. The pelvis after surgery and radio-chemotherapy for rectal cancer studies with Gd-DTPA-enhanced fast dynamic MR imaging. Eur Radiol 1998; 8:781-787.
22. Kelvin FM, Koronkin M, Heaston DK, Grant JP, Akwari O. The pelvis after surgery for rectal carcinoma: serial CT observations with emphasis on nonneoplastic features. AJR Am J Roentgenol 1983; 141: 959-964.
23. Ito K, Kato T, Tadokoro M, et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 1992; 182:549-552.
24. Muller-Schimpfle M, Brix G, Layer G, et al. Recurrent rectal cancer: diagnosis with dynamic MR imaging. Radiology 1993; 189:881-889.
25. Kinkel K, Tardivon A, Soyer P. et al. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients. Radiology 1996; 200:453-458.
26. Nuyttens JJ, Robertson JM, Yan D, Martinez A. The position and volume of small bowel during adjuvant radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2001; 51:1271-1280.
27. Koelbl O, Richter S, Flentje M. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model. Int J Radiat Oncol Biol Phys 1999; 45:1193-1198.
28. Jager PL, Slart RH, Corstens F, Oyen WJ, Hoekstra O, Teule J. PET-CT: a matter of opinion? (letter). Eur J Nucl Med Mol Imaging 2003; 30:470-471.
29. Valk PE, Abella-Columna E, Hasemann MK, et al. Whole-body PET imaging with F-18 fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 1999; 134:503-513.